126 related articles for article (PubMed ID: 29888852)
1. Topical axitinib is a potent inhibitor of corneal neovascularization.
Lledó Riquelme M; Campos-Mollo E; Fernández-Sánchez L
Clin Exp Ophthalmol; 2018 Dec; 46(9):1063-1074. PubMed ID: 29888852
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model.
Pérez-Santonja JJ; Campos-Mollo E; Lledó-Riquelme M; Javaloy J; Alió JL
Am J Ophthalmol; 2010 Oct; 150(4):519-528.e1. PubMed ID: 20591397
[TBL] [Abstract][Full Text] [Related]
3. KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.
Li T; Hu A; Li S; Luo Y; Huang J; Yu H; Ma W; Pan J; Zhong Q; Yang J; Wu J; Tang S
Mol Vis; 2011 Mar; 17():797-803. PubMed ID: 21528000
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical and subconjunctival use of bevacizumab on corneal neovascularization in rabbits' eyes.
Lopes GJA; Casella AMB; Oguido AP; Matsuo T
Arq Bras Oftalmol; 2017; 80(4):252-256. PubMed ID: 28954027
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Effects of Dovitinib and Bevacizumab on Reducing Neovascularization in an Experimental Rat Corneal Neovascularization Model.
Sahan B; Ciftci F; Eyuboglu S; Yaba A; Yilmaz B; Yalvac BI
Cornea; 2019 Sep; 38(9):1161-1168. PubMed ID: 31180924
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
Koh CH; Lee HS; Chung SK
Cornea; 2014 May; 33(5):527-32. PubMed ID: 24608256
[TBL] [Abstract][Full Text] [Related]
7. [Vascular morphological and microdensity changes of corneal neovascularization induced by topical bevacizumab and sunitinib in an animal model].
Pérez-Santonja JJ; Campos-Mollo E; Lledó-Riquelme M; Fernández-Sánchez L; Cuenca-Navarro N
Arch Soc Esp Oftalmol; 2013 Dec; 88(12):473-81. PubMed ID: 24257257
[TBL] [Abstract][Full Text] [Related]
8. The effect of bevacizumab on corneal neovascularization in rabbits.
Kim WJ; Jeong HO; Chung SK
Korean J Ophthalmol; 2010 Aug; 24(4):230-6. PubMed ID: 20714387
[TBL] [Abstract][Full Text] [Related]
9. Effect of metronidazole ophthalmic solution on corneal neovascularization in a rat model.
Claros-Chacaltana FDY; Aldrovani M; Kobashigawa KK; Padua IRM; Valdetaro GP; de Barros Sobrinho AAF; Abreu TGM; Laus JL
Int Ophthalmol; 2019 May; 39(5):1123-1135. PubMed ID: 29700650
[TBL] [Abstract][Full Text] [Related]
10. NK1 receptor antagonists as a new treatment for corneal neovascularization.
Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Topical Pigment Epithelium-Derived Factor (PEDF) with Topical Bevacizumab for Accelerating the Regression of Corneal Neovascularization in an Experimental Model of Rabbit Corneal Angiogenesis.
Mahmoudzadeh R; Heidari-Keshel S; Mehrpour M; Asadi Amoli F; Aghajanpour L; Lashay A
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1471-1477. PubMed ID: 32407187
[No Abstract] [Full Text] [Related]
12. Efficacy of fumagillin bicyclohexylamine on experimental corneal neovascularization in rat model.
Aşula MF; Onur IU; Yigit FU
Int Ophthalmol; 2019 Jul; 39(7):1553-1558. PubMed ID: 30006905
[TBL] [Abstract][Full Text] [Related]
13. Effects of Combined Photodynamic Therapy and Topical Bevacizumab Treatment on Corneal Neovascularization in Rabbits.
Kim RY; Chung SK; Kim MS; Ra H
Cornea; 2016 Dec; 35(12):1615-1620. PubMed ID: 27684458
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.
Wu Y; Xue C; Lu Y; Huang Z
Indian J Ophthalmol; 2017 Nov; 65(11):1127-1132. PubMed ID: 29133637
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.
Park JH; Joo CK; Chung SK
Cornea; 2015 Apr; 34(4):449-55. PubMed ID: 25651492
[TBL] [Abstract][Full Text] [Related]
16. Topical dimethyl sulfoxide inhibits corneal neovascularization and stimulates corneal repair in rabbits following acid burn.
Altan S; Sağsöz H; Oğurtan Z
Biotech Histochem; 2017; 92(8):619-636. PubMed ID: 29233043
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
Papathanassiou M; Theodossiadis PG; Liarakos VS; Rouvas A; Giamarellos-Bourboulis EJ; Vergados IA
Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123
[TBL] [Abstract][Full Text] [Related]
18. Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.
Hashemian MN; Z-Mehrjardi H; Moghimi S; Tahvildari M; Mojazi-Amiri H
Ophthalmic Res; 2011; 46(1):50-4. PubMed ID: 21212709
[TBL] [Abstract][Full Text] [Related]
19. Treatment of corneal neovascularization by topical application of ascorbic acid in the rabbit model.
Lee MY; Chung SK
Cornea; 2012 Oct; 31(10):1165-9. PubMed ID: 22832865
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of corneal neovascularization by vascular endothelial growth inhibitor gene].
Wang B; Wang CF; Wang LH; Pang Q
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):929-33. PubMed ID: 19176123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
